AMED
Amedisys
AMED
AMED
Delisted
AMED was delisted on the 14th of August, 2025.
169 hedge funds and large institutions have $2.08B invested in Amedisys in 2017 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 71 increasing their positions, 47 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 152 → 169 (+17)
0.79% less ownership
Funds ownership: 98.76% → 97.97% (-0.79%)
89% less call options, than puts
Call options by funds: $1.97M | Put options by funds: $17.4M
Holders
169
Holding in Top 10
2
Calls
$1.97M
Puts
$17.4M
Top Buyers
| 1 | +$31.2M | |
| 2 | +$15.1M | |
| 3 | +$14M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$7.74M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
+$6.24M |
Top Sellers
| 1 | -$39.6M | |
| 2 | -$22M | |
| 3 | -$10.6M | |
| 4 |
BlackRock
New York
|
-$9.83M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$9.38M |